Cancer Institute of New Jersey at University Hospital ( Site 1762) — Newark, New Jersey

Cancer Institute of New Jersey at University Hospital ( Site 1762) is a clinical research site located in Newark, New Jersey, United States 07103.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Cancer Institute of New Jersey at University Hospital ( Site 1762) has participated in 1 clinical trials.

Therapeutic areas: Cervical Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newark

Browse all research sites in New Jersey · View every site in Newark

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Institute of New Jersey at University Hospital ( Site 1762)?

Cancer Institute of New Jersey at University Hospital ( Site 1762) has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Institute of New Jersey at University Hospital ( Site 1762) conducted?

Cancer Institute of New Jersey at University Hospital ( Site 1762) has 1 clinical trials on record. Their work covers Cervical Cancer.

Is Cancer Institute of New Jersey at University Hospital ( Site 1762) accredited by Crixeo Clinical Trials?

Cancer Institute of New Jersey at University Hospital ( Site 1762) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Institute of New Jersey at University Hospital ( Site 1762)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.